Broad expertise in cellular immunology, infectious diseases and autoimmunity. Experience in establishing and validating mouse models, including those humanized, to drive pharmacokinetic/pharmcodynamic studies to gain understanding of drug/biologic efficacy, proof-of-Biology and safety. Proven ability inleading/managing multiple collaborative research programs with academic, bio-pharmaceuticals and CRO partners.

Senior Scientist @ In vivo pharmacology From January 2015 to Present (1 year) Senior Research Fellow @ * Scientific - Development and optimization of a novel platform technology to generate therapeutic human monoclonal antibodies *Leadership and Strategy - Innovate, manage and promote the humanized mouse program (www.humouse.org) From January 2007 to December 2014 (8 years) Postdoctoral Fellow @ *Identification and characterization of mode of action of antimicrobial compounds against anthrax From December 2004 to December 2006 (2 years 1 month) Postdoctoral Fellow @ *Optimization of DNA based vaccines against infectious diseases including HIV and Hepatitis C virus (HCV) * Development of an alternate non human primate model system to study HCV pathogenesis and vaccine efficacy From July 2001 to December 2004 (3 years 6 months)

Master of Business Administration (MBA), High Tech MBA @ Northeastern University From 2004 to 2007 Doctor of Philosophy (Ph.D.), Biochemistry @ Indian Institute of Science, Bangalore, India From 1995 to 2001 Subhabrata Biswas is skilled in: Molecular Biology, Cell Biology, Immunology, vaccines, Translational Research